MedPath
HSA Approval

Alfuzosin PH&T 10mg prolonged-release tablets

SIN13819P

Alfuzosin PH&T 10mg prolonged-release tablets

Alfuzosin PH&T 10mg prolonged-release tablets

June 21, 2010

NOVEM HEALTHCARE PTE LTD

NOVEM HEALTHCARE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVEM HEALTHCARE PTE LTD
Licence HolderNOVEM HEALTHCARE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, EXTENDED RELEASE

ORAL

Medical Information

G04CA01

alfuzosin

Manufacturer Information

NOVEM HEALTHCARE PTE LTD

MIPHARM S.P.A

Active Ingredients

Alfuzosin hydrochloride

10.000 mg

Alfuzosin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Alfuzosin PH&T 10mg prolonged-release tablets - HSA Approval | MedPath